If the drug price negotiation program had been in effect in 2021, Part D drug prices would have fallen 63 percent and ...

The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies ...

The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were ...

Controls on drug prices will stifle our ability to innovate while also damaging the economy, Alexandria economist Justin Vélez-Hagan, Ph.D., writes in a guest column.

While so-called “march-in” rights have yet to materialize in the United States, the controversial measure to cut drug prices appears to be gaining traction with the government. | While so-called ...

We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...

Under the Inflation Reduction Act (IRA) of 2022, the Centers for Medicare and Medicaid Services (CMS) will begin negotiating drug prices for a subset of drugs in Medicare. In doing so, CMS must ...

For customers, employers and health insurers paying for prescriptions, the change will have mixed outcomes. While some drugs may become more expensive, more should become cheaper, CVS executives said.

It was a huge defeat for Big Pharma when Congress and President Joe Biden enacted a law aimed in part at lowering ...

State officials approached 23 drugmakers in the last year about an importation program. None expressed interest in ...

A smarmy executive is all over Washington these days, which is really nothing new. But this particular suit is everywhere. And according to the lobbying group behind the commercials he stars in ...

The third-quarter earnings season has just concluded for the drug and biotech sector. The performance of the large drugmakers was rather lukewarm, with most posting mixed results. Higher tax rates ...